ProShares Ultra NASDAQ Biotechnology
19 hedge funds and large institutions have $2.12M invested in ProShares Ultra NASDAQ Biotechnology in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
19
Holding in Top 10
–
Calls
$710K
Puts
–
Top Buyers
| 1 | +$393K | |
| 2 | +$28.1K | |
| 3 | +$888 | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$74 |
Top Sellers
| 1 | -$655K | |
| 2 | -$567K | |
| 3 | -$534K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$381K |
| 5 |
CIA
Capital Investment Advisors
Atlanta,
Georgia
|
-$7.4K |
